en

PRODUCT DETAIL

Brineura 150 mg infúzny roztok

Code 4681C
MA number EU/1/17/1192/001
Product Form: sol inf 2x5 ml/150 mg+1x5 ml prepl.roztok (liek.inj.skl.)
MA Status: Ev - Valid centralised marketing authorisation under exceptional circumstances
Type of procedure: EU Orphan
Therapeutic Class: 87 - VARIA I
ATC:
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB17 Cerliponase alfa
Shelf life: 24
Container: glass vial
Route of admin.: Intracerebroventricular use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 30.05.2017
Validity: 01.06.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 28.07.2022
eu-flag.png sk-flag.png